SEC Form D filing
Embold Therapeutics, Inc., 2026-02-09
An SEC Form D private-offering notice from Redwood City, CA, a $4,975,000 filer-stated offering target in Biotech. Filed 2026-02-09. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Embold Therapeutics, Inc. Verified via SEC Form D
Filed 2026-02-09Filed to raise $4,975,000First money in 2026-01-21Raised so far $2,470,587HQ (as filed) Redwood City, CASector Biotech machine-classified from the filing aloneStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 1 executive & director
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Also filed for this raise
every source Form D behind this opportunityOther Form D filings from the same week
each with its own page and its own EDGAR source- Mivium, Inc., 2026-02-10, $3M, South El Monte, CA
- California Cultured Inc., 2026-02-10, $8.1M, West Sacramento, CA
- ASTRO HEALTH INC, 2026-02-09, $10M, San Francisco, CA
- Critical Reagent Processing Corp., 2026-02-10, $45K, Vancouver, BC, Canada
- Rice Studio Inc., 2026-02-09, $6M, Palo Alto, CA
- Cytodyme, Inc., 2026-02-09, $2.5M, San Diego, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.